DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 1 filers reported holding DYNE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 32.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,582 | -24.3% | 7,989 | -4.9% | 0.00% | -33.3% |
| Q2 2023 | $94,534 | +630126.7% | 8,403 | +560.1% | 0.00% | – |
| Q1 2023 | $15 | +66.7% | 1,273 | +73.2% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 735 | -92.3% | 0.00% | -100.0% |
| Q3 2022 | $122,000 | +838.5% | 9,582 | +425.0% | 0.00% | – |
| Q2 2022 | $13,000 | -94.9% | 1,825 | -93.2% | 0.00% | -100.0% |
| Q1 2022 | $257,000 | +2041.7% | 26,644 | +2442.4% | 0.00% | – |
| Q4 2021 | $12,000 | -47.8% | 1,048 | -28.1% | 0.00% | -100.0% |
| Q3 2021 | $23,000 | -37.8% | 1,458 | -17.4% | 0.00% | 0.0% |
| Q2 2021 | $37,000 | +208.3% | 1,765 | +120.1% | 0.00% | – |
| Q1 2021 | $12,000 | +33.3% | 802 | +78.6% | 0.00% | – |
| Q4 2020 | $9,000 | +350.0% | 449 | +265.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |